| Literature DB >> 32944525 |
Yisen Meng1,2,3, Wei Yu1,2,3, Zhenhua Liu1,2,3, Muqiu Zhang1,2,3, Yuke Chen1,2,3, Shaobo Li4, Yu Fan1,2,3, Shuai Hu1,2,3, Kai Zhang1,2,3, Qian Zhang1,2,3, Jie Jin1,2,3.
Abstract
BACKGROUND: The distribution characteristics of inflammatory cells in hyperplastic prostatic tissue and its influences on disease development remain unknown. We aimed to explore the infiltration characteristics of different inflammatory cells in histological structures of benign prostatic hyperplasia (BPH) in combination with clinical data.Entities:
Keywords: B-lymphocytes; Benign prostatic hyperplasia (BPH); T-lymphocytes; inflammation; macrophages
Year: 2020 PMID: 32944525 PMCID: PMC7475681 DOI: 10.21037/tau-20-448
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Classification of inflammatory infiltration in prostate
| Classification | Description |
|---|---|
| Localization | Histologic type |
| Glandular | Inflammatory cells infiltrate the glandular/ductal epithelium and/or lumen |
| Periglandular | Inflammatory cells infiltrate the stroma, centered on a gland/duct, less than 50 μm from the gland/duct |
| Stromal | Inflammatory cells infiltrate the stroma, more than 50 μm from the gland/duct |
| Extent | Tissue area involved by inflammatory cell infiltrates |
| Focal | <10% |
| Multifocal | 10–50% |
| Diffuse | >50% |
| Grade | Morphological description (density of inflammatory cells, number of cells/mm2) |
| 1/Mild | Isolated inflammatory cells, distributed in interstitial spaces (<100) |
| 2/Moderate | Inflammatory cells aggregate and appear in sheets, without tissue destruction or lymphoid nodules/follicular formation (100–500) |
| 3/Severe | Inflammatory cells aggregate and appear in sheets, with tissue destruction or lymphoid nodules/follicular formation (>500) |
Figure 1Glandular, periglandular and stromal inflammatory infiltration of varying degrees (H&E staining, ×200). (A,B,C) Glandular inflammation: (A) grade 1 (mild, in 51.3% patients); (B) grade 2 (moderate, in 22.4% patients); (C) Grade 3 (severe, in 1.3% patients). (D,E,F) Periglandular inflammation: (D) grade 1 (mild, in 46.1% patients); (E) grade 2 (moderate, in 42.1% patients); (F) grade 3 (Severe, in 6.6% patients). (G,H,I) Stromal inflammation: (G) grade 1 (mild, in 35.5% patients); (H) grade 2 (moderate, in 38.2% patients); (I) grade 3 (severe, in 14.5% patients).
Univariable and multiple regression analysis of prostate volume
| Variables | Univariable regression analysis | Multivariable regression analysis | |||
|---|---|---|---|---|---|
| Co-efficient | P value | Co-efficient | P value | ||
| Age | 0.323 | 0.004* | 0.262 | 0.010* | |
| Hypertension | 0.228 | 0.047* | 0.191 | 0.059 | |
| Diabetes | 0.120 | 0.303 | – | – | |
| Grading of glandular inflammation | 0.357 | 0.002* | 0.251 | 0.015* | |
| Grading of periglandular inflammation | 0.368 | 0.001* | 0.180 | 0.082 | |
| Grading of stromal inflammation | 0.337 | 0.003* | 0.217 | 0.037* | |
P value was analyzed by univariate or multivariate regression analysis. *, P<0.05.
Figure 2T-lymphocytes, B-lymphocytes and macrophages infiltration of varying degrees [CD3 staining in (A,B,C), CD20 staining in (D,E,F), CD68 staining in (G,H,I); IHC, ×200]. (A,B,C) T-lymphocytes infiltration: (A) glandular (in 27.6% patients); (B) periglandular (in 77.6% patients); (C) stromal (in 55.3% patients). (D,E,F) B-lymphocytes inflammation: (D) glandular (in 35.5% patients); (E) periglandular (in 38.2% patients); (F) stromal (in 14.5% patients). (G,H,I) Macrophages infiltration: (G) glandular (in 26.3% patients); (H) periglandular (in 28.9% patients); (I) stromal (in 22.4% patients).
Comparison of the distribution of different inflammatory cells
| Variables | T-lymphocytes (N=76) | B-lymphocytes (N=76) | Macrophages (N=76) | P value |
|---|---|---|---|---|
| Glandular infiltration, n (%) | 0.003* | |||
| No | 55 (72.4) | 70 (92.1) | 56 (73.7) | |
| Yes | 21 (27.6) | 6 (7.9) | 20 (26.3) | |
| Periglandular infiltration, n (%) | <0.001* | |||
| No | 17 (22.4) | 28 (36.8) | 54 (71.1) | |
| Yes | 59 (77.6) | 48 (63.2) | 22 (28.9) | |
| Stromal infiltration, n (%) | <0.001* | |||
| No | 34 (44.7) | 45 (59.2) | 59 (77.6) | |
| Yes | 42 (55.3) | 31 (40.8) | 17 (22.4) |
P value was analyzed by Chi-square test analysis. *, P<0.05.
Figure S1Representative histological photomicrographs of epithelial or stromal hyperplasia of BPH specimens (H&E staining, ×100). In the epithelial hyperplasia-dominant BPH patients’ tissue, tall columnar prostatic epithelial cells are often seen, with prominent hyperplasia protruding into the glandular cavity. There is a marked increase in glands with glandular (adenomatous) nodules or mixed nodules around the glands. In the stromal hyperplasia-dominant BPH patients’ tissue, stromal thickening/nodules, adenomyoid-type nodules, or fibroadenoma type nodules are often seen. (A) Representative histological photomicrographs of epithelial hyperplasia; (B) representative histological photomicrographs of stromal hyperplasia. BPH, benign prostatic hyperplasia.
Comparison of the distribution of inflammatory cells in different pathological types
| Variables | T-lymphocytes | B-lymphocytes | Macrophages | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Glandular hyperplasia dominated (N=44) | Stromal hyperplasia dominated (N=32) | P value | Glandular hyperplasia dominated (N=44) | Stromal hyperplasia dominated (N=32) | P value | Glandular hyperplasia dominated (N=44) | Stromal hyperplasia dominated (N=32) | P value | |||
| Glandular infiltration, n (%) | 0.662 | 0.204 | 0.453 | ||||||||
| No | 31 (70.5) | 24 (75.0) | 42 (95.5) | 28 (87.5) | 31 (70.5) | 25 (78.1) | |||||
| Yes | 13 (29.5) | 8 (25.0) | 2 (4.5) | 4 (12.5) | 13 (29.5) | 7 (21.9) | |||||
| Periglandular infiltration, n (%) | 0.113 | 0.560 | 0.706 | ||||||||
| No | 7 (15.9) | 10 (31.3) | 15 (34.1) | 13 (40.6) | 32 (72.7) | 22 (68.8) | |||||
| Yes | 37 (84.1) | 22 (68.8) | 29 (65.9) | 19 (59.4) | 12 (27.3) | 10 (31.3) | |||||
| Stromal infiltration, n (%) | <0.001* | 0.164 | 0.639 | ||||||||
| No | 28 (63.6) | 6 (18.8) | 29 (65.9) | 16 (50.0) | 35 (79.5) | 24 (75.0) | |||||
| Yes | 16 (36.4) | 26 (81.3) | 15 (34.1) | 16 (50.0) | 9 (20.5) | 8 (25.0) | |||||
P value was analyzed by Chi-square test analysis. *, P<0.05.
Further analysis on the association of different type of immune cell infiltration and prostate volume
| Variables | T-lymphocytes | B-lymphocytes | Macrophages | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number, n (%) | Prostate volume (mL) | P value | Number, n (%) | Prostate volume (mL) | P value | Number, n (%) | Prostate volume (mL) | P value | |||
| Glandular infiltration | 0.393 | 0.558 | 0.218 | ||||||||
| No | 55 (72.4) | 90.42 | 70 (92.1) | 91.50 | 56 (73.7) | 85.09 | |||||
| Yes | 21 (27.6) | 95.85 | 6 (7.9) | 96.83 | 20 (26.3) | 111.05 | |||||
| Periglandular infiltration | 0.799 | 0.078 | 0.050 | ||||||||
| No | 17 (22.4) | 90.45 | 28 (36.8) | 79.16 | 54 (71.1) | 83.69 | |||||
| Yes | 59 (77.6) | 92.35 | 48 (63.2) | 99.36 | 22 (28.9) | 112.13 | |||||
| Stromal infiltration | 0.077 | 0.977 | 0.924 | ||||||||
| No | 34 (44.7) | 81.38 | 45 (59.2) | 92.06 | 59 (77.6) | 91.65 | |||||
| Yes | 42 (55.3) | 100.46 | 31 (40.8) | 91.73 | 17 (22.4) | 92.88 | |||||
P value was analyzed by t-test analysis.
Relationship between obesity and the distribution of inflammatory cells in the prostate
| Variables | Obesity | P value | |
|---|---|---|---|
| No | Yes | ||
| Glandular inflammation | 0.010* | ||
| Mild | 40 (85.1) | 17 (58.6) | |
| Moderate–severe | 7 (14.9) | 12 (41.4) | |
| Periglandular inflammation | 0.706 | ||
| Mild | 19 (40.4) | 13 (44.8) | |
| Moderate–severe | 28 (59.6) | 16 (55.2) | |
| Stromal inflammation | 0.521 | ||
| Mild | 24 (51.1) | 17 (58.6) | |
| Moderate–severe | 23 (48.9) | 12 (41.4) | |
P value was analyzed by Chi-square test analysis. *, P<0.05.
Univariable and multiple regression analysis of total serum PSA level
| Variables | Univariable regression analysis | Multiple regression analysis | |||
|---|---|---|---|---|---|
| Co-efficient | P value | Co-efficient | P value | ||
| Age | 0.129 | 0.268 | – | – | |
| Prostate volume | 0.331 | 0.003* | 0.271 | 0.035* | |
| Grading of glandular inflammation | 0.264 | 0.021* | 0.248 | 0.031* | |
| Grading of periglandular inflammation | 0.361 | 0.001* | 0.106 | 0.356 | |
| Grading of stromal inflammation | 0.345 | 0.002* | 0.216 | 0.061 | |
P value was analyzed by univariate or multivariate regression analysis. *, P<0.05. PSA, prostate-specific antigen.
Further analysis on the association of different type of immune cell infiltration and total serum PSA level
| Variables | T-lymphocytes | B-lymphocytes | Macrophages | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number, n (%) | Mean PSA | P value | Number, n (%) | Mean PSA | P value | Number, n (%) | Mean PSA | P value | |||
| Glandular infiltration | 0.003* | 0.558 | 0.218 | ||||||||
| No | 55 (72.4) | 4.83 | 70 (92.1) | 5.91 | 56 (73.7) | 5.96 | |||||
| Yes | 21 (27.6) | 8.57 | 6 (7.9) | 5.28 | 20 (26.3) | 5.58 | |||||
| Periglandular infiltration | 0.001* | 0.562 | 0.920 | ||||||||
| No | 17 (22.4) | 4.59 | 28 (36.8) | 4.98 | 54 (71.1) | 5.59 | |||||
| Yes | 59 (77.6) | 6.23 | 48 (63.2) | 6.38 | 22 (28.9) | 6.53 | |||||
| Stromal infiltration | 0.054 | 0.910 | 0.792 | ||||||||
| No | 34 (44.7) | 5.07 | 45 (59.2) | 6.11 | 59 (77.6) | 5.78 | |||||
| Yes | 42 (55.3) | 6.50 | 31 (40.8) | 5.51 | 17 (22.4) | 6.16 | |||||
P value was analyzed by t-test analysis. *, P<0.05. PSA, prostate-specific antigen.